FundedIQ
Medical Equipment Manufacturing

Presidio Medical

Presidio Medical is a medtech company that develops a transformational neuromodulation platform. It enables people to receive remedies for disorders affecting neuronal activity.

presidiomedical.com South San Francisco, United States 11-50 employees
Total raised
$72.0M
Rounds
1
Latest
Series C
Jun 2023

Presidio Medical is a medtech company that develops a transformational neuromodulation platform. It enables people to receive remedies for disorders affecting neuronal activity.

Presidio Medical has raised $72.0M across 1 round. Its most recent round was a Series C of $72.0M in Jun 2023. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Jun 26, 2023
Series C
$72.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Presidio Medical is featured in

Similar companies

Provisio Medical, Inc.

By creating Sonic Lumen Tomography (SLTTM), a revolutionary intravascular ultrasound technique that gives precise and accurate real-time flow lumen dimensions, Provisio Medical hopes to transform endovascular operations. Additionally, the SLT platform may be simply incorporated into many of the endovascular devices that doctors now use. Provisio's SLT platform aims to effortlessly give doctors the information they need, when they need it, to improve clinical workflows and outcomes, without the drawbacks of low-resolution angiography's ionizing radiation and kidney-toxic contrast medium. Provisio's SLT technology is establishing a new paradigm in intravascular measures for evaluating clinical presentation, directing treatment choices including the appropriate sizing of therapeutic endovascular devices, and verifying the conclusion of treatment regimens.

Series Unknown $1.3M
Tetrous
Series A $6.5M
Openwater

Openwater is creating advanced imaging technologies that offer high resolution at a low cost. These advancements will support medical diagnoses and treatments, as well as enable more accessible brain-to-computer communication.

Series Unknown $54.0M
UNandUP

UN&UP is an organization that helps people with unmet needs and those who are underprivileged.

Series Unknown $3.1M
Neochord Inc

Among patients with mitral valve regurgitation, NeoChord, a privately held medical technology business, is advancing mitral valve repair in the beating heart. NeoChord Artificial Chordae Delivery System, the company's flagship product, obtained CE market clearance in December 2012.

Series Unknown $2.9M
Embolx

A startup medical device business in Silicon Valley called Embolx is creating microcatheters for artery embolization operations. Embolx is dedicated to significantly enhancing the management of a number of ailments, such as malignant tumors, benign prostatic hyperplasia, and uterine fibroids. The Sniper balloon occlusion microcatheter raises the bar for precision embolic administration and superior target filling by directing blood flow while safeguarding neighboring tissues that are not the target.

Series Unknown $1.6M
Galen Robotics

Galen Robotics is creating a single-platform solution to assist surgeons in a variety of specialties with no disruption to current workflows. Our cooperative control paradigm seeks to end hand tremor and allow surgeons to do accurate, minimally invasive procedures in otolaryngology, head and neck surgery, and tissue reconstruction that were previously thought to be beyond the capabilities of humans.

Series A $15.0M
ThinkStream.ai

ThinkStream is an AI powered assistant transforming inbox chaos into focused, goal-driven workstreams.

Seed $20k
Vast

Vast develops commercial space stations and plans crewed missions with SpaceX, supporting research, production, and habitation.

Series A $150M
OmniSpeech

OmniSpeech™ is an innovative software technology company that aims to revolutionize the enhancement of voice quality in IP communications.

Pre-Seed $500k
Empathium

Empathium is an AI-powered emotional intelligence platform training human centered communication and care.

Seed $10k
Maritime Fusion

Maritime Fusion specializes in the development and construction of high-temperature superconducting fusion reactors.

Seed $4.5M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.